Sep 12, 2018 Targeted genome editing as "next generation drugs" for Parkinson's disease Targeted genome editing as “next generation drugs” for Parkinson’s diseaseOrnit Chiba-Falek, GCB member and associate professor of neurology, collaborated with Boris Kantor, assistant research professor in neurobiology, ... read morePublished on 2018-09-12